BETH ISRAEL DEACONESS MEDICAL CENTER
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
Not Applicable
Terminated
- Conditions
- Estrogen Receptor Positive Breast CancerBreast CancerNode-negative Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Interventions
- Other: Breast Cancer Treatment Decision Aid for women 70+Other: Usual Care
- First Posted Date
- 2016-07-06
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT02823262
- Locations
- πΊπΈ
Dana Farber Cancer Institute, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
Phase 2
Completed
- Conditions
- Hidradenitis Suppurativa
- Interventions
- Drug: 23.4% Hypertonic saline
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT02805595
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Effects of Open-label vs Double-blind Treatment in IBS
Not Applicable
Completed
- Conditions
- Irritable Bowel SyndromePlacebo EffectPlacebosPeppermint Oil
- Interventions
- Dietary Supplement: peppermint oilDrug: placebo
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 340
- Registration Number
- NCT02802241
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
Phase 2
Completed
- Conditions
- Liver Transplantation
- Interventions
- Biological: Interleukin-2
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2022-12-19
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 7
- Registration Number
- NCT02739412
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
Early Phase 1
Completed
- Conditions
- Acute Kidney Injury
- Interventions
- Drug: Oral niacinamide, 3 gram dailyDrug: PlaceboDrug: Oral niacinamide, 1 gram daily
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 55
- Registration Number
- NCT02701127
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Identification of L3-L4 Interspace in Parturients
Completed
- Conditions
- Healthy
- Interventions
- Other: Education
- First Posted Date
- 2016-03-03
- Last Posted Date
- 2021-10-01
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT02697747
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
Not Applicable
Terminated
- Conditions
- Critical IllnessPositive-Pressure Respiration, IntrinsicBrain InjuriesRespiratory FailureIntracranial HypertensionLung Injury
- Interventions
- Other: PEEP titrated mechanical ventilation
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2019-02-22
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT02680704
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Activation of Brain Centers by Short-term Walnut Consumption in Obesity
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Other: Placebo shakeOther: Walnut shake
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02673281
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Clinical Research Center, Boston, Massachusetts, United States
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: Cardiac Magnetic Resonance Imaging (CMR)Other: Echocardiogram (ECHO)
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT02666378
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
A Randomized Comparison of the Use of JET and Conventional Ventilation in Pulmonary Vein Isolation
Not Applicable
Terminated
- Conditions
- Atrial Fibrillation
- Interventions
- Device: Jet VentilationDevice: Conventional ventilation
- First Posted Date
- 2016-01-27
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT02664311
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States